153 related articles for article (PubMed ID: 6802839)
1. Direct interaction of mepacrine with erythrocyte and platelet membrane phospholipid.
Dise CA; Burch JW; Goodman DB
J Biol Chem; 1982 May; 257(9):4701-4. PubMed ID: 6802839
[TBL] [Abstract][Full Text] [Related]
2. Mepacrine (quinacrine) inhibition of thrombin-induced platelet responses can be overcome by lysophosphatidic acid.
McCrea JM; Robinson P; Gerrard JM
Biochim Biophys Acta; 1985 Oct; 842(2-3):189-94. PubMed ID: 3931692
[TBL] [Abstract][Full Text] [Related]
3. Mobilization of arachidonic acid in thrombin-stimulated human platelets.
Mahadevappa VG; Sicilia F
Biochem Cell Biol; 1990 Feb; 68(2):520-7. PubMed ID: 2111711
[TBL] [Abstract][Full Text] [Related]
4. The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface.
Winocour PD; Kinlough-Rathbone RL; Mustard JF
Thromb Haemost; 1981 Jun; 45(3):257-62. PubMed ID: 7281105
[TBL] [Abstract][Full Text] [Related]
5. Effect of membrane cholesterol on phospholipid metabolism in thrombin-stimulated platelets. Enhanced activation of platelet phospholipase(s) for liberation of arachidonic acid.
Kramer RM; Jakubowski JA; Vaillancourt R; Deykin D
J Biol Chem; 1982 Jun; 257(12):6844-9. PubMed ID: 7085608
[TBL] [Abstract][Full Text] [Related]
6. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
Brammer JP; Maguire MH
Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
[TBL] [Abstract][Full Text] [Related]
7. Evidence for predominance of phospholipase A2 in release of arachidonic acid in thrombin-activated platelets: phosphatidylinositol-specific phospholipase C may play a minor role in arachidonate liberation.
Imai A; Yano K; Kameyama Y; Nozawa Y
Jpn J Exp Med; 1982 Apr; 52(2):99-105. PubMed ID: 6811781
[TBL] [Abstract][Full Text] [Related]
8. Platelet and erythrocyte membrane lipid and phospholipid patterns in different types of mental patients.
Sengupta N; Datta SC; Sengupta D
Biochem Med; 1981 Jun; 25(3):267-75. PubMed ID: 7271762
[No Abstract] [Full Text] [Related]
9. The effects of mepacrine and p-bromophenacyl bromide on arachidonic acid release in human platelets.
Hofmann SL; Prescott SM; Majerus PW
Arch Biochem Biophys; 1982 Apr; 215(1):237-44. PubMed ID: 6807207
[No Abstract] [Full Text] [Related]
10. The distribution and metabolism of arachidonic acid in rabbit platelets during aggregation and its modification by drugs.
Blackwell GJ; Duncombe WG; Flower RJ; Parsons MF; Vane JR
Br J Pharmacol; 1977 Feb; 59(2):353-66. PubMed ID: 837023
[TBL] [Abstract][Full Text] [Related]
11. Asymmetry of arachidonic acid metabolism in the phospholipids of the human platelet membrane as studied with purified phospholipases.
Plantavid M; Perret BP; Chap H; Simon MF; Douste-Blazy L
Biochim Biophys Acta; 1982 Dec; 693(2):451-60. PubMed ID: 6818991
[TBL] [Abstract][Full Text] [Related]
12. The inhibition of arachidonic acid mobilization in human platelets by R59 022, a diacylglycerol kinase inhibitor.
Mahadevappa VG; Sicilia FJ
Biochim Biophys Acta; 1988 Aug; 961(3):309-15. PubMed ID: 2840967
[TBL] [Abstract][Full Text] [Related]
13. Mepacrine blockade of arachidonate-induced washed platelet aggregation: relationship to mepacrine inhibition of platelet cyclooxygenase.
Raz A
Thromb Haemost; 1983 Dec; 50(4):784-6. PubMed ID: 6420923
[TBL] [Abstract][Full Text] [Related]
14. Differences in the pattern of attack of acidic, neutral, and basic phospholipase A2 of A. halys blomhofii on human erythrocyte membranes: problems in interpretation of phospholipid location.
Shukla SD; Hanahan DJ
Arch Biochem Biophys; 1981 Jul; 209(2):668-76. PubMed ID: 7294816
[No Abstract] [Full Text] [Related]
15. Limited hydrolysis of platelet membrane phospholipids. On the proposed phospholipase-susceptible domain in platelet membranes.
Kannagi R; Koizumi K; Masuda T
J Biol Chem; 1981 Feb; 256(3):1177-84. PubMed ID: 7451497
[No Abstract] [Full Text] [Related]
16. Different susceptibilities of platelet phospholipids to various phospholipases and modifications induced by thrombin. Possible evidence of rearrangement of lipid domains.
Wang CT; Tsai WJ; Chang SM; Shiao YJ; Yang CC
Biochim Biophys Acta; 1987 May; 899(2):205-12. PubMed ID: 3580366
[TBL] [Abstract][Full Text] [Related]
17. Activation of phospholipase A2 and beta-thromboglobulin release in human platelets: comparative effects of thrombin and fluoroaluminate stimulation.
Stasi M; Gresele P; Porcellati S; Quero E; Nenci GG; Goracci G
Biochim Biophys Acta; 1992 Mar; 1124(3):279-87. PubMed ID: 1315576
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of calmodulin antagonists on phospholipases A2 and C in thrombin-stimulated platelets.
Walenga RW; Opas EE; Feinstein MB
J Biol Chem; 1981 Dec; 256(23):12523-8. PubMed ID: 6795206
[No Abstract] [Full Text] [Related]
19. Definition of the pathway for membrane phospholipid fatty acid turnover in human erythrocytes.
Dise CA; Goodman DB; Rasmussen H
J Lipid Res; 1980 Mar; 21(3):292-300. PubMed ID: 7381324
[TBL] [Abstract][Full Text] [Related]
20. Effects of phospholipase A2 treatment of human erythrocyte membranes on the rates of spectrin-actin dissociation.
Gottlieb MH
Biochim Biophys Acta; 1982 Mar; 686(1):133-6. PubMed ID: 7066319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
